Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muller

Showing results (1141-1150 of 1,237) with videos related to

Pageof 124
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 1, 2023
Identification of Sociodemographic, Clinical, and Genetic Factors to Aid Alaska Native and American Indian People to Successfully Quit SmokingJaedon P Avey, Krista R Schaefer, Carolyn J Noonan, et al.
Cancer Cell|September 8, 2009
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transitionJing Lu, Hua Guo, Warapen Treekitkarnmongkol, et al.
Cell Research|March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumorsOzgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Cancers|April 1, 2020
Tetraspanin CD9 is Regulated by miR-518f-5p and Functions in Breast Cell Migration and In Vivo Tumor GrowthDanielle R Bond, Richard Kahl, Joshua S Brzozowski, et al.
Nature Communications|July 13, 2016
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancerGeneviève Deblois, Harvey W Smith, Ingrid S Tam, et al.
Cancer Research|May 31, 2013
β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progressionBabette Schade, Robert Lesurf, Virginie Sanguin-Gendreau, et al.
The Journal of Clinical Investigation|April 15, 1996
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndromeA C Crawley, D A Brooks, V J Muller, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
Cell Reports|May 3, 2018
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer ProgressionMarie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
Pageof 124

Showing results (1141-1150 of 1,237) with videos related to

Sort By:
Pageof 124
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 1, 2023
Identification of Sociodemographic, Clinical, and Genetic Factors to Aid Alaska Native and American Indian People to Successfully Quit SmokingJaedon P Avey, Krista R Schaefer, Carolyn J Noonan, et al.
Cancer Cell|September 8, 2009
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transitionJing Lu, Hua Guo, Warapen Treekitkarnmongkol, et al.
Cell Research|March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumorsOzgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Cancers|April 1, 2020
Tetraspanin CD9 is Regulated by miR-518f-5p and Functions in Breast Cell Migration and In Vivo Tumor GrowthDanielle R Bond, Richard Kahl, Joshua S Brzozowski, et al.
Nature Communications|July 13, 2016
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancerGeneviève Deblois, Harvey W Smith, Ingrid S Tam, et al.
Cancer Research|May 31, 2013
β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progressionBabette Schade, Robert Lesurf, Virginie Sanguin-Gendreau, et al.
The Journal of Clinical Investigation|April 15, 1996
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndromeA C Crawley, D A Brooks, V J Muller, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
Cell Reports|May 3, 2018
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer ProgressionMarie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
Pageof 124